Drugs of the Future Q4 Unclaimed
Drugs of the Future is an interdisciplinary biomedical research journal that publishes well-documented, peer-reviewed articles on topics emerging from the confluence of scientific fields including chemistry, biology, pharmacology, genomics and medicine. The journal identifies and anticipates new trends, advances and breakthroughs in basic, translational and clinical research, and includes the following sections: It has an SJR impact factor of 0,15.
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy: Non Open Access
Type of publications:
Publication frecuency: -
- €
Inmediate OA- €
Embargoed OA0 €
Non OAMetrics
0,15
SJR Impact factor46
H Index7
Total Docs (Last Year)262
Total Docs (3 years)208
Total Refs27
Total Cites (3 years)261
Citable Docs (3 years)0.09
Cites/Doc (2 years)29.71
Ref/DocOther journals with similar parameters
Bangladesh Journal of Pharmacology Q4
European Journal of Oncology Pharmacy Q4
Pharmaceutical Chemistry Journal Q4
Prescrire International Q4
Biomedical and Pharmacology Journal Q4
Compare this journals
Aims and Scope
Best articles by citations
Penbutolol
View moreHalopredone Diacetate
View moreX-linked hypophosphatemia: Understanding and management
View moreMemantine
View moreDBCO
View moreProquazone
View moreL-10503
View moreLR 511
View moreLR 534
View moreDefactinib hydrochloride. Dual FAK1/PYK2 inhibitor, Treatment of non-small cell lung cancer, treatment of malignant mesothelioma, treatment of ovarian cancer
View moreAliflurane
View moreGemcadiol
View moreAlletorphine
View moreMorocromen
View moreNorgestimate
View moreD-32
View moreN-propylnoraporphine
View moreGYKI-13504
View moreClazolimine
View moreButibufen
View moreCartazolate
View moreGemfibrozil
View moreCloprednol
View moreTocainide
View more
Comments